Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Asiasari radix extract may relieve certain types of pain by affecting GABA and NMDA receptors.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

The FDA did not approve a testosterone drug because of safety concerns.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

New compounds may help treat prostate issues without affecting androgen receptors.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.